eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Prospective Grant of Exclusive License: Use of Anti-TAG72 Monoclonal Antibodies as a Tumor-Specific Imaging Agent and Drug Delivery Therapeutic

Prospective Grant of Exclusive License: Use of Anti-TAG72 Monoclonal Antibodies as a Tumor-Specific Imaging Agent and Drug Delivery Therapeutic

Document ID: NIH_FRDOC_0001-0210
Document Type: Notice
Agency: National Institutes Of Health
Topics: No Topics associated with this document
Federal Register Number: E7-22595
View Document:  View as format pdf View as format html

Details Information

Received Date: November 19 2007, at 07:09 AM Eastern Standard Time
Start-End Page: 65053 - 65054
Page Count: 2
Comment Start Date: November 19 2007, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.